ES2108059T3 - Procedimiento para la purificacion de anticuerpos monoclonales igg. - Google Patents

Procedimiento para la purificacion de anticuerpos monoclonales igg.

Info

Publication number
ES2108059T3
ES2108059T3 ES92108912T ES92108912T ES2108059T3 ES 2108059 T3 ES2108059 T3 ES 2108059T3 ES 92108912 T ES92108912 T ES 92108912T ES 92108912 T ES92108912 T ES 92108912T ES 2108059 T3 ES2108059 T3 ES 2108059T3
Authority
ES
Spain
Prior art keywords
monoclonal antibodies
purification
procedure
antibodies igg
igg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92108912T
Other languages
English (en)
Inventor
Norbert Dr Kothe
Dieter Dr Rudnick
Detlef Dr Rohm
Ulf Dr Bethke
Michael Dr Kloft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest Pharma GmbH
Original Assignee
Biotest Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Pharma GmbH filed Critical Biotest Pharma GmbH
Application granted granted Critical
Publication of ES2108059T3 publication Critical patent/ES2108059T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCESO PARA LA LIMPIEZA DE ANTICUERPOS MONOCLONALES IGG POR COMBINACION DE TRES PASOS DE CROMATOGRAFIA, A SABER, EN UN CAMBIADOR DE ANIONES, EN UN CAMBIADOR DE CATIONES Y EN UNA FASE HIDROFOBA CON UN PASO DE ESTERILIZACION ESPECIFICO. POR ELLO SE OBTIENE UNA SOLUCION DE ANTICUERPOS CON UNA PUREZA DE POR LO MENOS EL 99,5 % QUE, POR CONSIGUIENTE, SE PUEDE EMPLEAR EN INMUNOTERAPIA POR VIA INTRAVENOSA.
ES92108912T 1991-06-08 1992-05-27 Procedimiento para la purificacion de anticuerpos monoclonales igg. Expired - Lifetime ES2108059T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4118912A DE4118912C1 (es) 1991-06-08 1991-06-08

Publications (1)

Publication Number Publication Date
ES2108059T3 true ES2108059T3 (es) 1997-12-16

Family

ID=6433511

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92108912T Expired - Lifetime ES2108059T3 (es) 1991-06-08 1992-05-27 Procedimiento para la purificacion de anticuerpos monoclonales igg.

Country Status (7)

Country Link
EP (1) EP0530447B1 (es)
JP (1) JP2644946B2 (es)
AT (1) ATE159532T1 (es)
DE (2) DE4118912C1 (es)
DK (1) DK0530447T3 (es)
ES (1) ES2108059T3 (es)
GR (1) GR3025603T3 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2706466B1 (fr) * 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
IL121900A (en) * 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
IL140155A (en) * 1998-06-09 2005-12-18 Statens Seruminstitut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
DK2270044T3 (en) 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
JPWO2004087761A1 (ja) * 2003-03-31 2006-07-27 麒麟麦酒株式会社 ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
EP1532983A1 (en) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
CN101679509A (zh) 2007-06-01 2010-03-24 弗·哈夫曼-拉罗切有限公司 免疫球蛋白纯化
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
CL2008002053A1 (es) 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
WO2009058769A1 (en) * 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
JP2012513425A (ja) 2008-12-22 2012-06-14 エフ．ホフマン−ラ ロシュ アーゲー 免疫グロブリンの精製
WO2011095543A1 (en) 2010-02-04 2011-08-11 Csl Behring Ag Immunoglobulin preparation
CN102762585B (zh) 2010-02-12 2016-01-20 DPx控股有限公司 单一单元抗体纯化
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
CN103118708B (zh) 2010-09-14 2015-08-26 霍夫曼-拉罗奇有限公司 用于纯化聚乙二醇化的促红细胞生成素的方法
AU2011325341B2 (en) * 2010-11-01 2015-12-17 Dpx Holdings B.V. Single unit ion exchange chromatography antibody purification
JP6116565B2 (ja) 2011-08-25 2017-04-19 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 陽イオンおよび陰イオン交換クロマトグラフィー法
EP2596812B1 (de) * 2011-11-22 2015-06-10 Heraeus Medical GmbH Sterilisation von polymerisierbaren Monomeren
KR101917196B1 (ko) * 2014-03-11 2018-11-09 주식회사 녹십자홀딩스 면역글로불린의 정제방법
ES2988823T3 (es) 2014-12-03 2024-11-21 Csl Behring Ag Producto farmacéutico con mayor estabilidad que comprende inmunoglobulinas
KR102470282B1 (ko) 2016-07-15 2022-11-24 에프. 호프만-라 로슈 아게 Ｐｅｇ화 에리트로포이에틴을 정제하기 위한 방법
JP2022523063A (ja) * 2019-01-30 2022-04-21 アムジエン・インコーポレーテツド アフリベルセプトの属性、並びにその特性決定及び修飾方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469630A (en) * 1983-11-25 1984-09-04 J. T. Baker Chemical Co. Purification of monoclonal antibodies
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
CA1323567C (en) * 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
CA2005600A1 (en) * 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor

Also Published As

Publication number Publication date
GR3025603T3 (en) 1998-03-31
DK0530447T3 (da) 1998-01-12
DE59208982D1 (de) 1997-11-27
JPH07267997A (ja) 1995-10-17
JP2644946B2 (ja) 1997-08-25
DE4118912C1 (es) 1992-07-02
EP0530447A3 (en) 1993-08-18
ATE159532T1 (de) 1997-11-15
EP0530447B1 (de) 1997-10-22
EP0530447A2 (de) 1993-03-10

Similar Documents

Publication Publication Date Title
ES2108059T3 (es) Procedimiento para la purificacion de anticuerpos monoclonales igg.
DK0821695T3 (da) Oprensning af antistof ved hydrofob interaktionschromatografi ved lav pH-værdi
NZ509135A (en) A third generation intravenous immunoglobulin G (IVIG) purified using column chromatographic ion exchange methods
CA2183888A1 (en) Antibody purification
DZ1731A1 (fr) Procédé de préparation d'oléfines légères par déshydrogenation des paraffines correspondantes.
DK0538754T3 (da) Anvendelse af antistofholdige præparater til immunundertrykkelse
ES8506902A1 (es) Un procedimiento para la purificacion de un antigeno.
Saluk et al. The unique molecular weight of the heavy chain from human IgG3
GR3015229T3 (en) Method for producung an unmodified intravenous IgM- and/or IgA-containing immunoglobulin preparation.
EP0282317A3 (en) Purified platelet-derived growth factor and methods for purification thereof
DK407987D0 (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
DE3688100D1 (de) Polyvalentes hyperimmunglobulin-praeparat.
AU5406800A (en) Method for carrying out the chromatographic fractionation of plasma or serum, preparations obtained thereby and their use
DK0597358T3 (da) Fremgangsmåde til kvantitativ oprensning af glycolipider
Fey A simple procedure for the production of Fab from bovine IgG as an absorbent in the preparation of class-specific anti-immunoglobulin
DK0672685T3 (da) Monoklonalt antistof specifik for tumor cytotoxisk faktor (TCF-11)
AU2124692A (en) A process for the purification of factor xiii, monoclonal antibodies against factor xiiia, the preparation and use thereof
EP0536564A3 (en) Method to purify streptolysin o, intact streptolysin o obtainable by this method and its use
Goudswaard et al. Isolation of equine IgG (T) by hydrophobic interaction chromatography
AU1626492A (en) Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
IT1237997B (it) Assorbenti tiofilici
ATE193021T1 (de) Lipoprotein (a)-peptide und deren verwendung
FR2637893B1 (fr) Procede de preparation de la methylhydroquinone

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 530447

Country of ref document: ES